top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
The art of nanomaterials / / Amin. A. El-Meligi
The art of nanomaterials / / Amin. A. El-Meligi
Autore El-Meligi Amin. A.
Edizione [1st ed.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (115 pages)
Disciplina 620.115
Soggetto topico Nanostructured materials
Nanotechnology
Soggetto non controllato Nanoscience
Science
ISBN 9781681089706
9781681089713
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910796076603321
El-Meligi Amin. A.  
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The art of nanomaterials / / Amin. A. El-Meligi
The art of nanomaterials / / Amin. A. El-Meligi
Autore El-Meligi Amin. A.
Edizione [1st ed.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (115 pages)
Disciplina 620.115
Soggetto topico Nanostructured materials
Nanotechnology
Soggetto non controllato Nanoscience
Science
ISBN 9781681089706
9781681089713
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910820183003321
El-Meligi Amin. A.  
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Artificial intelligence based cancer nanomedicine : diagnostics, therapeutics and bioethics / / edited by Fahima Dilnawaz and Ajit Kumar Behura
Artificial intelligence based cancer nanomedicine : diagnostics, therapeutics and bioethics / / edited by Fahima Dilnawaz and Ajit Kumar Behura
Edizione [First edition.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (110 pages) : illustrations
Disciplina 610.285
Soggetto topico Artificial intelligence - Medical applications
Cancer - Treatment
Drug delivery systems
Nanomedicine
Bioethical Issues
Artificial Intelligence
Neoplasms - therapy
ISBN 981-5050-56-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY -- UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) -- ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
Artificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR -- ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy -- Artificial Intelligence-Driven Approach for Future Healthcare System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENT -- REFERENCES -- Artificial Intelligence-Enabled Model for Predicting the Metastatic Potential of Cancer Cells -- Sarbari Acharya1,* and Chandana Mohanty1 -- INTRODUCTION -- CANCER METASTASIS -- DIAGNOSIS OF CANCER METASTASIS -- ARTIFICIAL INTELLIGENCE AND CANCER DETECTION -- ROLE OF AI MODELS FOR PREDICTING CANCER METASTASIS -- FUTURE PERSPECTIVES AND CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence for Cancer Nanotheranostics -- Sarbari Acharya1,* -- INTRODUCTION -- CANCER IMAGING -- THERANOSTICS AND NANOTHERANOSTICS -- ROLE OF NANOTHERANOSTICS IN CANCER MANAGEMENT.
AI IN NANOMEDICINE FOR CANCER THERAPY -- AI AND NANOTHERANOSTICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Ethical Dimensions of Using Artificial Intelligence in Healthcare -- Ajit Kumar Behura1,* -- INTRODUCTION -- ETHICAL CONSIDERATIONS WHEN USING AI IN HEALTH CARE -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover.
Record Nr. UNINA-9910795739803321
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Artificial intelligence based cancer nanomedicine : diagnostics, therapeutics and bioethics / / edited by Fahima Dilnawaz and Ajit Kumar Behura
Artificial intelligence based cancer nanomedicine : diagnostics, therapeutics and bioethics / / edited by Fahima Dilnawaz and Ajit Kumar Behura
Edizione [First edition.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (110 pages) : illustrations
Disciplina 610.285
Soggetto topico Artificial intelligence - Medical applications
Cancer - Treatment
Drug delivery systems
Nanomedicine
Bioethical Issues
Artificial Intelligence
Neoplasms - therapy
ISBN 981-5050-56-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY -- UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) -- ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
Artificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR -- ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy -- Artificial Intelligence-Driven Approach for Future Healthcare System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENT -- REFERENCES -- Artificial Intelligence-Enabled Model for Predicting the Metastatic Potential of Cancer Cells -- Sarbari Acharya1,* and Chandana Mohanty1 -- INTRODUCTION -- CANCER METASTASIS -- DIAGNOSIS OF CANCER METASTASIS -- ARTIFICIAL INTELLIGENCE AND CANCER DETECTION -- ROLE OF AI MODELS FOR PREDICTING CANCER METASTASIS -- FUTURE PERSPECTIVES AND CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence for Cancer Nanotheranostics -- Sarbari Acharya1,* -- INTRODUCTION -- CANCER IMAGING -- THERANOSTICS AND NANOTHERANOSTICS -- ROLE OF NANOTHERANOSTICS IN CANCER MANAGEMENT.
AI IN NANOMEDICINE FOR CANCER THERAPY -- AI AND NANOTHERANOSTICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Ethical Dimensions of Using Artificial Intelligence in Healthcare -- Ajit Kumar Behura1,* -- INTRODUCTION -- ETHICAL CONSIDERATIONS WHEN USING AI IN HEALTH CARE -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover.
Record Nr. UNINA-9910820624103321
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers in medicine / / edited by Pinar Atukeren and Hafize Uzun
Biomarkers in medicine / / edited by Pinar Atukeren and Hafize Uzun
Autore Atukeren Pınar
Edizione [1st ed.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (739 pages)
Disciplina 610.28
Soggetto topico Biomedical engineering
Radiology
Biomarkers
Biomarkers, Tumor
Soggetto non controllato Biochemical Markers
Clinical Biochemistry
Science
Medical
ISBN 981-5040-46-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- New Biomarkers and Immunotherapy Decision -- Abdurrahman Yigit1, Berkay Kuscu2, Ali Kirik2, Ruhsen Ozcaglayan2 and Cigdem Usul Afsar3,* -- NEW BIOMARKERS AND IMMUNOTHERAPY DECISION -- Principles of Cancer İmmunotherapy -- Tumor Immunology -- Therapeutic Approaches -- Immune Checkpoint Inhibitors (ICI) -- THE PREDICTIVE AND PROGNOSTIC MARKERS OF IMMUNOTHERAPY -- Immunotherapy Toxicity -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Biomarkers in Gynecologic Tumors -- Selim Afsar1,* -- INTRODUCTION -- Ovarian and Fallopian Tube Cancers -- Carbohydrate Antigen 125 (CA125) -- Screening -- Prediction Models -- Prognosis -- Recurrence -- Human Epididymis Protein 4 (HE4) -- Diagnosis -- Prognosis -- Risk of Ovarian Malignancy Algorithm (ROMA) -- Circulating Cell-Free DNA (cfDNA) -- DNA Methylation -- Metabolites -- MicroRNAs -- Carcinoembryonic Antigen (CEA) -- Alpha-Fetoprotein (AFP) -- Inhibin B -- Human Chorionic Gonadotropin (hCG) -- Kallikreins -- Other Markers -- Uterine Cancer -- CA125 -- HE4 -- Genomic Classification -- Other Markers -- Cervical Cancer -- Squamous Cell Carcinoma Antigen (SCC-Ag) -- Other Markers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Biomarkers in Urological Cancers -- Bulent Onal1,*, Mehmet Hamza Gultekin1, Muhammed Fatih Simsekoglu1, Berin Selcuk1 and Ahmet Gurbuz1 -- BIOMARKERS IN BLADDER CANCER -- Blood-based Biomarkers -- Tumor Cells -- CD8 Count and Immune Cells -- Matrix Metalloproteinase -- Epigenetic Markers -- Tissue-based Biomarkers -- Cell Cycle-based Markers -- Transmembrane- and Signaling-based Markers -- PDL/PDL1 -- mTOR -- MDR1 -- Human Epidermal Growth Factor Receptor 2 (HER2).
Apoptosis- and DNA Repair-Based Markers -- Multiplexed Markers -- Twenty-Gene Panel, GenomeDX Gene-Expression Assay -- Urine-based Biomarkers -- Fluorescence In situ Hybridization (FISH) -- Bladder Tumor Antigen (BTA) Tests -- Nuclear Matrix Protein-22 (NMP-22) Test -- ImmunoCyt Test -- CxBladder Test -- SUMMARY -- BIOMARKERS IN PROSTATE CANCER -- Blood-Based Biomarkers -- PSA or hK3 -- Free PSA (fPSA) -- Prostate Health Index (PHI) -- 4Kscore Test -- Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) -- Prostate-Specific Membrane Antigen (PSMA) -- Urine-Based Biomarkers -- PCA3 -- Gene Fusion -- SelectMDx -- Annexin A3 -- Tissue-Based Biomarkers -- α-Methylacyl Coenzyme A Racemase (AMACR) -- Epigenetic Modifications -- Genomic Expression Profiles -- Inherited Genetic Markers -- SUMMARY -- BIOMARKERS IN RENAL CELL CARCINOMA -- Diagnostic Biomarkers -- Carbonic Anhydrase IX (CAIX) -- Gene Expression Profile -- Urine Biomarkers -- Tissue Biomarkers -- Prognostic Biomarkers -- Routine Blood Biomarkers -- Von Hippel-Lindau (VHL) Gene -- VEGF -- Survivin -- p53 -- Ki-67 -- Phosphatase and Tensin Homolog (PTEN) -- Predictive Biomarkers -- Immune Checkpoint Inhibitors -- mTOR Inhibitors -- Pediatric Renal Tumors: -- SUMMARY -- BIOMARKERS IN TESTICULAR CANCER -- Alfa-fetoprotein (AFP) -- Human Chorionic Gonodotropin (HCG) -- Lactate Dehydrogenase (LDH) -- Potential Biomarkers in Future -- Placental Alkaline Phosphatase (PLAP) -- Oct-3/4, Sall 4, and CD 117 -- miRNAs -- SUMMARY -- NEXT GENERATION SEQUENCING -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Circulating Biomarkers in Thyroid Cancer -- Lebriz Uslu-Beşli1,* -- INTRODUCTION -- THYROID GLAND -- CLASSIFICATION OF THYROID CANCER -- MEDICAL MANAGEMENT OF THYROID CANCER -- Differentiated Thyroid Cancer -- Medullary Thyroid Cancer.
Anaplastic Thyroid Cancer -- SEROLOGICAL BIOMARKERS -- Thyroglobulin -- Anti-thyroglobulin Antibodies -- Calcitonin and Procalcitonin -- Carcinoembryonic Antigen -- Other Peptides -- LIQUID BIOPSY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- DNA Methylation Biomarkers in Cancer: Current Clinical Utility and Future Perspectives -- Sinem Durmus1,*, Remise Gelisgen1 and Hafize Uzun2 -- INTRODUCTION -- DNA METHYLATION AND REGULATION MECHANISM -- DNA Methylation in Cancer -- Regional Hypermethylation -- Global Hypomethylation -- DNA Methylation Biomarkers in Cancer -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Circulating Biomarkers in Predicting Pathological Response to Neoadjuvant Therapy for Colorectal Cancer -- Ravindri Jayasinghe1, Umesh Jayarajah1,* and Sanjeewa Seneviratne1 -- INTRODUCTION -- ESTABLISHED BIOMARKERS -- Tissue Based Biomarkers -- DNA Alterations: Polymorphisms -- Gene Expression -- MicroRNA (miRNA) -- Blood Based Biomarkers -- cfDNA and ctDNA -- cfmRNA and hTERT -- cfmiRNA -- CIRCULATING PROTEINS/PEPTIDES -- OTHER PREDICTIVE BIOMARKERS -- Thymidylate Synthase (TS) -- Epidermal Growth Factor Receptor (EGFR) -- Cyclooxygenase 2 (COX-2) -- Bax/bcl-2 -- P21 -- Ki-67 -- CEA -- ctDNA -- Circulating Tumour Cells (CTC) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERANCES -- Circulating Biomarkers in the Management of Breast Cancer -- Ravindri Jayasinghe1, Umesh Jayarajah1,* and Sanjeewa Seneviratne1 -- INTRODUCTION -- ESTABLISHED BIOMARKERS -- Carcinoembryonic Antigen (CEA) -- MUC-1 -- HER-2 -- Cytokeratins (CK) -- Specific Classes of Circulatory Biomarkers -- Proteins -- Autoantibodies -- Circulating Tumour Cells (CTC) -- Exosomes -- MicroRNA (miRNA) -- Circulating Cell-Free DNA (cfDNA).
BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF BREAST CANCER -- MONITORING RESPONSE TO THERAPY AND SURVEILLANCE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Clinical Application of Biomarkers for Hematologic Malignancies -- Nurgül Özgür Yurttaş1 and Ahmet Emre Eşkazan1,* -- INTRODUCTION -- BIOMARKERS IN MYELOID NEOPLASMS -- Acute Myeloid Leukemia -- CYTOGENETIC CLASSIFICATION OF AML -- MRD IN AML -- Myelodysplastic Syndrome -- CHROMOSOMAL ABNORMALITIES IN MDS -- Deletions of Chromosome 5 -- Monosomy 7 and Deletions of Chromosome 7 -- Diagnosis and Classification -- 5q-syndrome/MDS with an Isolated del(5q) -- Role of Cytogenetics in the Prognosis of MDS -- GENETIC MUTATIONS IN MDS -- Myeloproliferative Neoplasms -- Mutations in PV, ET, and PMF -- BIOMARKERS IN CHRONIC MYELOID LEUKEMIA -- Prognostic Factors at the Time of Diagnosis -- Use of the Mutational Analysis in CML -- Identification of Molecular Markers of Progression -- BIOMARKERS IN LYMPHOID NEOPLASMS -- BIOMARKERS IN ACUTE LYMPHOBLASTIC LEUKEMIA/ LYMPHOMA -- CYTOGENETIC AND MOLECULAR ABNORMALITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA -- B-ALL/LBL with Recurrent Genetic Abnormalities -- T-ALL/LBL -- Cytogenetic Abnormalities in T-ALL/LBL -- Molecular Abnormalities in T-ALL/LBL -- EARLY T-CELL PRECURSOR ALL/LBL -- MRD IN ALL -- BIOMARKERS IN LYMPHOMAS -- Biomarkers of Genetic Changes -- B-Cell Lymphoma 6 (BCL6) -- Tumor Protein 53 (TP53) -- V-Myc Avian Myelocytomatosis Viral Oncogene Homolog (MYC) -- B-Cell Lymphoma 2 (BCL2) -- Myeloid Differentiation Primary Response 88 (MYD88) -- Other Genetic Biomarkers in B-Cell Lymphomas -- Other Genetic Biomarkers in Peripheral T-Cell Lymphoma (PTCL) -- Biomarkers Related to Epigenetic Changes -- Other Epigenetic Gene Features -- MicroRNA and LncRNA in Diagnosis and Prognosis of Lymphomas.
Other MicroRNAs and MicroRNA-Based Classifiers -- Immunophenotypic Biomarkers -- CD30 -- Bcl-6, Bcl-2, and Myc -- Cyclin D1 and SOX-11 -- TP53 and MDM2 -- Immunophenotypic Biomarkers -- Immunohistochemical Biomarkers of Peripheral T-Cell Lymphoma -- Microenvironment-related Biomarkers for Prognosis and Immunotherapy -- BIOMARKERS IN MULTIPLE MYELOMA -- STAGING SYSTEMS -- GENOMIC BIOMARKERS -- Gene Expression Profiling -- NOVEL BIOMARKERS -- Minimal Residual Disease -- Next-Generation Biomarkers in MM -- Immunotherapy-related Biomarkers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Applications of Biomarkers in Cancer Surgery -- Berrin Papila Kundaktepe1,* -- INTRODUCTION -- CIRCULATING TUMOR MARKERS: CLINICAL APPLICATIONS -- Applications Of Tumor Markers In Colorectal Cancer -- Applications of Tumor Markers in Hepatocellular Carcinoma (HCC) -- Applications of Tumor Markers in Pancreatic Adenocarcinoma -- Applications of Tumor Markers In Breast Cancer -- Circulating Tumor Cells -- ENDOCRINE TUMOR MARKERS -- Immunohistochemical and Circulating Tumor Markers of NETs -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- A Pathophysiological Approach To Current Biomarkers -- Aykut Oruc1,* and Gonul Simsek1 -- CARDIAC BIOMARKERS -- Cardiac Troponins -- Troponin Subunits -- Regulatory Function of Troponin -- Cardiac Troponins as a Biomarker for Acute Myocardial Infarction: The Pathophysiology -- Cardiac Troponins as a Biomarker in Congestive Heart Failure -- Heart-Type Fatty Acid Binding Protein -- Heart-Type Fatty Acid Binding Protein in Acute Myocardial Ischemia -- Glycogen Phosphorylase Isoenzyme BB -- Myocardial Oxygen Deficiency and GPBB Release: The Pathophysiology -- Glutathione S-Transferase P1 -- N-Terminal pro-Brain Natriuretic Peptide.
Pathophysiological Mechanisms in Synthesis and Secretion of BNP and NT-proBNP.
Record Nr. UNINA-9910795982603321
Atukeren Pınar  
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers in medicine / / edited by Pinar Atukeren and Hafize Uzun
Biomarkers in medicine / / edited by Pinar Atukeren and Hafize Uzun
Autore Atukeren Pınar
Edizione [1st ed.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (739 pages)
Disciplina 610.28
Soggetto topico Biomedical engineering
Radiology
Biomarkers
Biomarkers, Tumor
Soggetto non controllato Biochemical Markers
Clinical Biochemistry
Science
Medical
ISBN 981-5040-46-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- New Biomarkers and Immunotherapy Decision -- Abdurrahman Yigit1, Berkay Kuscu2, Ali Kirik2, Ruhsen Ozcaglayan2 and Cigdem Usul Afsar3,* -- NEW BIOMARKERS AND IMMUNOTHERAPY DECISION -- Principles of Cancer İmmunotherapy -- Tumor Immunology -- Therapeutic Approaches -- Immune Checkpoint Inhibitors (ICI) -- THE PREDICTIVE AND PROGNOSTIC MARKERS OF IMMUNOTHERAPY -- Immunotherapy Toxicity -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Biomarkers in Gynecologic Tumors -- Selim Afsar1,* -- INTRODUCTION -- Ovarian and Fallopian Tube Cancers -- Carbohydrate Antigen 125 (CA125) -- Screening -- Prediction Models -- Prognosis -- Recurrence -- Human Epididymis Protein 4 (HE4) -- Diagnosis -- Prognosis -- Risk of Ovarian Malignancy Algorithm (ROMA) -- Circulating Cell-Free DNA (cfDNA) -- DNA Methylation -- Metabolites -- MicroRNAs -- Carcinoembryonic Antigen (CEA) -- Alpha-Fetoprotein (AFP) -- Inhibin B -- Human Chorionic Gonadotropin (hCG) -- Kallikreins -- Other Markers -- Uterine Cancer -- CA125 -- HE4 -- Genomic Classification -- Other Markers -- Cervical Cancer -- Squamous Cell Carcinoma Antigen (SCC-Ag) -- Other Markers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Biomarkers in Urological Cancers -- Bulent Onal1,*, Mehmet Hamza Gultekin1, Muhammed Fatih Simsekoglu1, Berin Selcuk1 and Ahmet Gurbuz1 -- BIOMARKERS IN BLADDER CANCER -- Blood-based Biomarkers -- Tumor Cells -- CD8 Count and Immune Cells -- Matrix Metalloproteinase -- Epigenetic Markers -- Tissue-based Biomarkers -- Cell Cycle-based Markers -- Transmembrane- and Signaling-based Markers -- PDL/PDL1 -- mTOR -- MDR1 -- Human Epidermal Growth Factor Receptor 2 (HER2).
Apoptosis- and DNA Repair-Based Markers -- Multiplexed Markers -- Twenty-Gene Panel, GenomeDX Gene-Expression Assay -- Urine-based Biomarkers -- Fluorescence In situ Hybridization (FISH) -- Bladder Tumor Antigen (BTA) Tests -- Nuclear Matrix Protein-22 (NMP-22) Test -- ImmunoCyt Test -- CxBladder Test -- SUMMARY -- BIOMARKERS IN PROSTATE CANCER -- Blood-Based Biomarkers -- PSA or hK3 -- Free PSA (fPSA) -- Prostate Health Index (PHI) -- 4Kscore Test -- Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) -- Prostate-Specific Membrane Antigen (PSMA) -- Urine-Based Biomarkers -- PCA3 -- Gene Fusion -- SelectMDx -- Annexin A3 -- Tissue-Based Biomarkers -- α-Methylacyl Coenzyme A Racemase (AMACR) -- Epigenetic Modifications -- Genomic Expression Profiles -- Inherited Genetic Markers -- SUMMARY -- BIOMARKERS IN RENAL CELL CARCINOMA -- Diagnostic Biomarkers -- Carbonic Anhydrase IX (CAIX) -- Gene Expression Profile -- Urine Biomarkers -- Tissue Biomarkers -- Prognostic Biomarkers -- Routine Blood Biomarkers -- Von Hippel-Lindau (VHL) Gene -- VEGF -- Survivin -- p53 -- Ki-67 -- Phosphatase and Tensin Homolog (PTEN) -- Predictive Biomarkers -- Immune Checkpoint Inhibitors -- mTOR Inhibitors -- Pediatric Renal Tumors: -- SUMMARY -- BIOMARKERS IN TESTICULAR CANCER -- Alfa-fetoprotein (AFP) -- Human Chorionic Gonodotropin (HCG) -- Lactate Dehydrogenase (LDH) -- Potential Biomarkers in Future -- Placental Alkaline Phosphatase (PLAP) -- Oct-3/4, Sall 4, and CD 117 -- miRNAs -- SUMMARY -- NEXT GENERATION SEQUENCING -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Circulating Biomarkers in Thyroid Cancer -- Lebriz Uslu-Beşli1,* -- INTRODUCTION -- THYROID GLAND -- CLASSIFICATION OF THYROID CANCER -- MEDICAL MANAGEMENT OF THYROID CANCER -- Differentiated Thyroid Cancer -- Medullary Thyroid Cancer.
Anaplastic Thyroid Cancer -- SEROLOGICAL BIOMARKERS -- Thyroglobulin -- Anti-thyroglobulin Antibodies -- Calcitonin and Procalcitonin -- Carcinoembryonic Antigen -- Other Peptides -- LIQUID BIOPSY -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- DNA Methylation Biomarkers in Cancer: Current Clinical Utility and Future Perspectives -- Sinem Durmus1,*, Remise Gelisgen1 and Hafize Uzun2 -- INTRODUCTION -- DNA METHYLATION AND REGULATION MECHANISM -- DNA Methylation in Cancer -- Regional Hypermethylation -- Global Hypomethylation -- DNA Methylation Biomarkers in Cancer -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Circulating Biomarkers in Predicting Pathological Response to Neoadjuvant Therapy for Colorectal Cancer -- Ravindri Jayasinghe1, Umesh Jayarajah1,* and Sanjeewa Seneviratne1 -- INTRODUCTION -- ESTABLISHED BIOMARKERS -- Tissue Based Biomarkers -- DNA Alterations: Polymorphisms -- Gene Expression -- MicroRNA (miRNA) -- Blood Based Biomarkers -- cfDNA and ctDNA -- cfmRNA and hTERT -- cfmiRNA -- CIRCULATING PROTEINS/PEPTIDES -- OTHER PREDICTIVE BIOMARKERS -- Thymidylate Synthase (TS) -- Epidermal Growth Factor Receptor (EGFR) -- Cyclooxygenase 2 (COX-2) -- Bax/bcl-2 -- P21 -- Ki-67 -- CEA -- ctDNA -- Circulating Tumour Cells (CTC) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERANCES -- Circulating Biomarkers in the Management of Breast Cancer -- Ravindri Jayasinghe1, Umesh Jayarajah1,* and Sanjeewa Seneviratne1 -- INTRODUCTION -- ESTABLISHED BIOMARKERS -- Carcinoembryonic Antigen (CEA) -- MUC-1 -- HER-2 -- Cytokeratins (CK) -- Specific Classes of Circulatory Biomarkers -- Proteins -- Autoantibodies -- Circulating Tumour Cells (CTC) -- Exosomes -- MicroRNA (miRNA) -- Circulating Cell-Free DNA (cfDNA).
BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF BREAST CANCER -- MONITORING RESPONSE TO THERAPY AND SURVEILLANCE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Clinical Application of Biomarkers for Hematologic Malignancies -- Nurgül Özgür Yurttaş1 and Ahmet Emre Eşkazan1,* -- INTRODUCTION -- BIOMARKERS IN MYELOID NEOPLASMS -- Acute Myeloid Leukemia -- CYTOGENETIC CLASSIFICATION OF AML -- MRD IN AML -- Myelodysplastic Syndrome -- CHROMOSOMAL ABNORMALITIES IN MDS -- Deletions of Chromosome 5 -- Monosomy 7 and Deletions of Chromosome 7 -- Diagnosis and Classification -- 5q-syndrome/MDS with an Isolated del(5q) -- Role of Cytogenetics in the Prognosis of MDS -- GENETIC MUTATIONS IN MDS -- Myeloproliferative Neoplasms -- Mutations in PV, ET, and PMF -- BIOMARKERS IN CHRONIC MYELOID LEUKEMIA -- Prognostic Factors at the Time of Diagnosis -- Use of the Mutational Analysis in CML -- Identification of Molecular Markers of Progression -- BIOMARKERS IN LYMPHOID NEOPLASMS -- BIOMARKERS IN ACUTE LYMPHOBLASTIC LEUKEMIA/ LYMPHOMA -- CYTOGENETIC AND MOLECULAR ABNORMALITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA -- B-ALL/LBL with Recurrent Genetic Abnormalities -- T-ALL/LBL -- Cytogenetic Abnormalities in T-ALL/LBL -- Molecular Abnormalities in T-ALL/LBL -- EARLY T-CELL PRECURSOR ALL/LBL -- MRD IN ALL -- BIOMARKERS IN LYMPHOMAS -- Biomarkers of Genetic Changes -- B-Cell Lymphoma 6 (BCL6) -- Tumor Protein 53 (TP53) -- V-Myc Avian Myelocytomatosis Viral Oncogene Homolog (MYC) -- B-Cell Lymphoma 2 (BCL2) -- Myeloid Differentiation Primary Response 88 (MYD88) -- Other Genetic Biomarkers in B-Cell Lymphomas -- Other Genetic Biomarkers in Peripheral T-Cell Lymphoma (PTCL) -- Biomarkers Related to Epigenetic Changes -- Other Epigenetic Gene Features -- MicroRNA and LncRNA in Diagnosis and Prognosis of Lymphomas.
Other MicroRNAs and MicroRNA-Based Classifiers -- Immunophenotypic Biomarkers -- CD30 -- Bcl-6, Bcl-2, and Myc -- Cyclin D1 and SOX-11 -- TP53 and MDM2 -- Immunophenotypic Biomarkers -- Immunohistochemical Biomarkers of Peripheral T-Cell Lymphoma -- Microenvironment-related Biomarkers for Prognosis and Immunotherapy -- BIOMARKERS IN MULTIPLE MYELOMA -- STAGING SYSTEMS -- GENOMIC BIOMARKERS -- Gene Expression Profiling -- NOVEL BIOMARKERS -- Minimal Residual Disease -- Next-Generation Biomarkers in MM -- Immunotherapy-related Biomarkers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Applications of Biomarkers in Cancer Surgery -- Berrin Papila Kundaktepe1,* -- INTRODUCTION -- CIRCULATING TUMOR MARKERS: CLINICAL APPLICATIONS -- Applications Of Tumor Markers In Colorectal Cancer -- Applications of Tumor Markers in Hepatocellular Carcinoma (HCC) -- Applications of Tumor Markers in Pancreatic Adenocarcinoma -- Applications of Tumor Markers In Breast Cancer -- Circulating Tumor Cells -- ENDOCRINE TUMOR MARKERS -- Immunohistochemical and Circulating Tumor Markers of NETs -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- A Pathophysiological Approach To Current Biomarkers -- Aykut Oruc1,* and Gonul Simsek1 -- CARDIAC BIOMARKERS -- Cardiac Troponins -- Troponin Subunits -- Regulatory Function of Troponin -- Cardiac Troponins as a Biomarker for Acute Myocardial Infarction: The Pathophysiology -- Cardiac Troponins as a Biomarker in Congestive Heart Failure -- Heart-Type Fatty Acid Binding Protein -- Heart-Type Fatty Acid Binding Protein in Acute Myocardial Ischemia -- Glycogen Phosphorylase Isoenzyme BB -- Myocardial Oxygen Deficiency and GPBB Release: The Pathophysiology -- Glutathione S-Transferase P1 -- N-Terminal pro-Brain Natriuretic Peptide.
Pathophysiological Mechanisms in Synthesis and Secretion of BNP and NT-proBNP.
Record Nr. UNINA-9910819897803321
Atukeren Pınar  
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Colorectal cancer diagnosis and therapeutic updates / / edited by Sankha Bhattacharya, Amit Page, Saurabh Maru & Shilpa Dawre
Colorectal cancer diagnosis and therapeutic updates / / edited by Sankha Bhattacharya, Amit Page, Saurabh Maru & Shilpa Dawre
Edizione [First edition.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (137 pages) : illustrations
Disciplina 616.994347
Soggetto topico Colon (Anatomy) - Cancer - Treatment
Colon (Anatomy) - Cancer - Diagnosis
Rectum - Cancer - Treatment
Rectum - Cancer - Diagnosis
Colorectal Neoplasms
ISBN 981-5040-94-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- Acknowledgement -- List of Contributors -- Colorectal Cancer Diagnosis -- Sankha Bhattacharya1,*, Amit Page1,*, Kapil Gore1,* and Amaiyya Agrawal1,* -- INTRODUCTION -- Invasive Examination -- NON-INVASIVE DIAGNOSIS METHODS -- Fecal Occult Blood Test -- Non-enzymatic Tumor Markers -- Lysosomal Exoglycosidases as Potential CRC Markers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Screening for Colorectal Carcinoma -- Sankha Bhattacharya1,*, Saurabh Maru1,* and Aseem Setia2,* -- INTRODUCTION -- DETECTION OF EARLY COLORECTAL CARCINOMA -- EARLY DIAGNOSIS OF COLORECTAL CARCINOMA -- WHAT IS SCREENING? -- WHO SHOULD BE SCREENED? -- SCREENING PEOPLE AT AN AVERAGE RISK FOR COLORECTAL CARCINOMA -- Fecal Occult Blood Test -- Flexible Sigmoidoscopy -- Combination of FOBT and Flexible Sigmoidoscopy -- Colonoscopy -- SCREENING PEOPLE AT INCREASED RISK FOR COLORECTAL CARCINOMA -- Genetic Syndromes -- NEW SCREENING TESTS -- CT Colonography -- Faecal Occult Blood Test -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Histopathology -- Sankha Bhattacharya1,*, Shilpa Dawre1,* and Dyanesh Saindane1,* -- INTRODUCTION -- NORMAL HISTOLOGY OF COLORECTAL AREA -- GENERAL PRESENTATION IN COLORECTAL CANCER -- NEED FOR HISTOPATHOLOGICAL INSPECTION IN COLORECTAL CARCINOMA -- FACTORS INVOLVED IN THE HISTOPATHOLOGICAL ANALYSIS OF COLORECTAL CARCINOMA -- HISTOPATHOLOGIC DIAGNOSIS OF COLORECTAL CANCER -- HISTOLOGIC VARIANTS -- GRADING OF COLORECTAL CARCINOMA USING HISTOPATHOLOGICAL ANALYSIS -- Process of Grading the Cancers -- Issues with PDC System and their Rectification -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
Chemotherapy and Colorectal Cancer -- Kapil Gore1,*, Dnyanesh Saindane1,* and Sankha Bhattacharya1,* -- INTRODUCTION -- CHEMOTHERAPY AND COLORECTAL CANCER -- Administration of Chemotherapeutic Agents -- CHEMOTHERAPY IN DIFFERENT STAGES OF COLORECTAL CANCER -- COMPONENTS OF CHEMOTHERAPY -- 5-Fluorouracil (5-FU) -- Irinotecan -- Oxaliplatin -- NOVEL THERAPIES FOR COLORECTAL CARCINOMA -- Agarose Microbeads -- Anti-inflammatory Agents -- Probiotics -- Functional Foods -- TARGETED THERAPIES -- Targeting EGFR -- Cetuximab and Panitumumab -- BRAF Inhibitors -- HER-2 Inhibitors -- Targeting VEGF -- Bevacizumab -- Novel anti-VEGFR Agents -- HGF/C-MET Pathway -- HGF Inhibitors -- MET Antagonists -- TKIs -- IMMUNE CHECKPOINT BLOCKADE -- ADJUVANT AND NEOADJUVANT THERAPY USING TARGETED MEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Robotics for Rectal Cancer -- Dnyanesh Saindane1, Ajay Madrewar1 and Sankha Bhattacharya1,* -- INTRODUCTION -- TOTAL MESORECTAL EXCISION -- Techniques Abdominoperineal Resection -- Coloanal Anastomosis -- LOCAL EXCISION -- Transanal Excision -- Transcoccygeal Excision -- Transsphincteric Excision -- Transanal Endoscopic Microsurgery -- DISADVANTAGES OF SURGICAL TREATMENT FOR RECTAL CANCER -- Short Term Effects of Surgery -- Long Term Effects -- LAPAROSCOPIC SURGERY -- ADVANTAGES OVER CONVENTIONAL SURGICAL METHODS -- Short Term Advantages Are: -- Long Term Advantages -- Limitations of Laparoscopic Surgery -- ROBOTIC SURGERY FOR COLORECTAL CANCER -- Components of the da Vinci surgical System -- Operation of the System -- OUTCOMES OF DA VINCI SURGICAL SYSTEM -- Short Term Outcomes -- Long Term Outcomes -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- lncRNA NLIPMT Inhibitors in Colorectal Cancer Management.
Aseem Setia1, Sankha Bhattacharya2,* and Amaiyya Agrawal2 -- INTRODUCTION -- LNCRNA IN COLORECTAL CANCER -- HOTAIR -- H19 -- MALAT 1 -- INVOLVEMENT OF LNCRNAS IN CRC PATHOGENESIS -- Wnt/β-Catenin Pathway -- EGFR/IGF-IR SIGNALING (PI3K AND KRAS PATHWAYS) -- TGF-Β SIGNALING PATHWAY -- P53. PATHWAY -- EMT PROGRAM -- DETAIL DISCUSSION OF EXPERIMENTAL DATA CONDUCTED FOR COLORECTAL CANCER (CRC) -- lncRNA Overexpression TGF-β1 Downregulation by NLIPMT Inhibits Colorectal Cancer Cell Migration and Invasion -- The Activation of KPNA3 by LncRNA DLEU1 Leads to the Advancement of Colorectal Cancer -- CONCLUSION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Pathways in Colorectal Cancer -- Ajay Madrewar1,*, Kapil Gore1 and Sankha Bhattacharya1 -- INTRODUCTION -- CHROMOSOMAL INSTABILITY PATHWAY -- Adenomatous Polyposis Coli gene and wnt Signaling Pathway -- TP-53 Mutation -- 18q Loss of Heterozygosity (LOH) -- MICROSATELLITE INSTABILITY PATHWAY -- EPIGENETIC INSTABILITY AND CPG METHYLATION -- PI3K/AKT PATHWAY, PTEN, AND TGFΒR2 -- SIGNALLING PATHWAYS IN COLORECTAL CANCER -- EGFR/MAPK Signaling Pathway -- Notch Signaling Pathway -- PI3K Signaling Pathway -- TGF-βsignalling Pathway -- Wnt Pathway -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Radiotherapy in Colorectal Cancer -- Amit Page1, Dnyanesh Saindane2 and Sankha Bhattacharya2,* -- INTRODUCTION -- TYPES OF RADIATION THERAPY -- CLINICAL TRIALS OR RESEARCH STUDIES OF RADIATION AND CHEMO-RADIATION THERAPY IN COLORECTAL CANCER -- Neoadjuvant Radiation Therapy -- Probable Side Effects of Radiotherapy -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Surveillance for Colorectal Cancer -- Saurabh Maru1, Kapil Gore1 and Sankha Bhattacharya1,*.
INTRODUCTION -- COLONOSCOPY -- FLEXIBLE SIGMOIDOSCOPY -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Recent Theranostics in Treatment of Colorectal Cancer -- Shilpa Dawre1, Ajay Madrewar1 and Sankha Bhattacharya1,* -- INTRODUCTION -- NANOFLATFORMS FOR DRUG DELIVERY AND THERANOSTICS -- NANOLIPOSOMAL BASED THERANOSTIC NANOPARTICLES -- Prodrug Approach -- SUPER MAGNETIC IRON-OXIDE NANOPARTICLES (SPIONS) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Management of Colorectal Cancer -- Sankha Bhattacharya1, Amit Page1, Saurabh Maru1 and Shilpa Dawre1 -- MANAGEMENT OF COLORECTAL CANCER -- HOW CAN YOU PREPARE PATIENTS FOR SURGERY? -- Enhanced Recovery After Surgery (ERAS) -- Stomal Therapy -- Bowel Preparation -- Nutritional Interventions -- LOCAL RECTAL TREATMENT OF RECTAL CANCER (CLINICS IN THE COLON A RECTAL) -- Tumor Evaluation -- Electrocoagulation -- Contract Radiotherapy -- Local Excision -- ENDOSCOPIC TREATMENT -- Snare Polypectomy -- Endoscopic Mucosal Resection (EMR) -- Endoscopic Submucosal Dissection -- WHAT IS THE SURGICAL OPTION FOR COLORECTAL CANCER? -- Open Surgery -- Laparoscopic Surgery -- WHAT ARE POSSIBLE COMPLICATIONS? -- Immediate -- Long Term -- WHAT IS THE ROLE OF ADJUVANT CHEMOTHERAPY IN COLORECTAL CANCER TREATMENT? -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover.
Record Nr. UNINA-9910795739403321
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Colorectal cancer diagnosis and therapeutic updates / / edited by Sankha Bhattacharya, Amit Page, Saurabh Maru & Shilpa Dawre
Colorectal cancer diagnosis and therapeutic updates / / edited by Sankha Bhattacharya, Amit Page, Saurabh Maru & Shilpa Dawre
Edizione [First edition.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Descrizione fisica 1 online resource (137 pages) : illustrations
Disciplina 616.994347
Soggetto topico Colon (Anatomy) - Cancer - Treatment
Colon (Anatomy) - Cancer - Diagnosis
Rectum - Cancer - Treatment
Rectum - Cancer - Diagnosis
Colorectal Neoplasms
ISBN 981-5040-94-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- Acknowledgement -- List of Contributors -- Colorectal Cancer Diagnosis -- Sankha Bhattacharya1,*, Amit Page1,*, Kapil Gore1,* and Amaiyya Agrawal1,* -- INTRODUCTION -- Invasive Examination -- NON-INVASIVE DIAGNOSIS METHODS -- Fecal Occult Blood Test -- Non-enzymatic Tumor Markers -- Lysosomal Exoglycosidases as Potential CRC Markers -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Screening for Colorectal Carcinoma -- Sankha Bhattacharya1,*, Saurabh Maru1,* and Aseem Setia2,* -- INTRODUCTION -- DETECTION OF EARLY COLORECTAL CARCINOMA -- EARLY DIAGNOSIS OF COLORECTAL CARCINOMA -- WHAT IS SCREENING? -- WHO SHOULD BE SCREENED? -- SCREENING PEOPLE AT AN AVERAGE RISK FOR COLORECTAL CARCINOMA -- Fecal Occult Blood Test -- Flexible Sigmoidoscopy -- Combination of FOBT and Flexible Sigmoidoscopy -- Colonoscopy -- SCREENING PEOPLE AT INCREASED RISK FOR COLORECTAL CARCINOMA -- Genetic Syndromes -- NEW SCREENING TESTS -- CT Colonography -- Faecal Occult Blood Test -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Histopathology -- Sankha Bhattacharya1,*, Shilpa Dawre1,* and Dyanesh Saindane1,* -- INTRODUCTION -- NORMAL HISTOLOGY OF COLORECTAL AREA -- GENERAL PRESENTATION IN COLORECTAL CANCER -- NEED FOR HISTOPATHOLOGICAL INSPECTION IN COLORECTAL CARCINOMA -- FACTORS INVOLVED IN THE HISTOPATHOLOGICAL ANALYSIS OF COLORECTAL CARCINOMA -- HISTOPATHOLOGIC DIAGNOSIS OF COLORECTAL CANCER -- HISTOLOGIC VARIANTS -- GRADING OF COLORECTAL CARCINOMA USING HISTOPATHOLOGICAL ANALYSIS -- Process of Grading the Cancers -- Issues with PDC System and their Rectification -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES.
Chemotherapy and Colorectal Cancer -- Kapil Gore1,*, Dnyanesh Saindane1,* and Sankha Bhattacharya1,* -- INTRODUCTION -- CHEMOTHERAPY AND COLORECTAL CANCER -- Administration of Chemotherapeutic Agents -- CHEMOTHERAPY IN DIFFERENT STAGES OF COLORECTAL CANCER -- COMPONENTS OF CHEMOTHERAPY -- 5-Fluorouracil (5-FU) -- Irinotecan -- Oxaliplatin -- NOVEL THERAPIES FOR COLORECTAL CARCINOMA -- Agarose Microbeads -- Anti-inflammatory Agents -- Probiotics -- Functional Foods -- TARGETED THERAPIES -- Targeting EGFR -- Cetuximab and Panitumumab -- BRAF Inhibitors -- HER-2 Inhibitors -- Targeting VEGF -- Bevacizumab -- Novel anti-VEGFR Agents -- HGF/C-MET Pathway -- HGF Inhibitors -- MET Antagonists -- TKIs -- IMMUNE CHECKPOINT BLOCKADE -- ADJUVANT AND NEOADJUVANT THERAPY USING TARGETED MEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Robotics for Rectal Cancer -- Dnyanesh Saindane1, Ajay Madrewar1 and Sankha Bhattacharya1,* -- INTRODUCTION -- TOTAL MESORECTAL EXCISION -- Techniques Abdominoperineal Resection -- Coloanal Anastomosis -- LOCAL EXCISION -- Transanal Excision -- Transcoccygeal Excision -- Transsphincteric Excision -- Transanal Endoscopic Microsurgery -- DISADVANTAGES OF SURGICAL TREATMENT FOR RECTAL CANCER -- Short Term Effects of Surgery -- Long Term Effects -- LAPAROSCOPIC SURGERY -- ADVANTAGES OVER CONVENTIONAL SURGICAL METHODS -- Short Term Advantages Are: -- Long Term Advantages -- Limitations of Laparoscopic Surgery -- ROBOTIC SURGERY FOR COLORECTAL CANCER -- Components of the da Vinci surgical System -- Operation of the System -- OUTCOMES OF DA VINCI SURGICAL SYSTEM -- Short Term Outcomes -- Long Term Outcomes -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- lncRNA NLIPMT Inhibitors in Colorectal Cancer Management.
Aseem Setia1, Sankha Bhattacharya2,* and Amaiyya Agrawal2 -- INTRODUCTION -- LNCRNA IN COLORECTAL CANCER -- HOTAIR -- H19 -- MALAT 1 -- INVOLVEMENT OF LNCRNAS IN CRC PATHOGENESIS -- Wnt/β-Catenin Pathway -- EGFR/IGF-IR SIGNALING (PI3K AND KRAS PATHWAYS) -- TGF-Β SIGNALING PATHWAY -- P53. PATHWAY -- EMT PROGRAM -- DETAIL DISCUSSION OF EXPERIMENTAL DATA CONDUCTED FOR COLORECTAL CANCER (CRC) -- lncRNA Overexpression TGF-β1 Downregulation by NLIPMT Inhibits Colorectal Cancer Cell Migration and Invasion -- The Activation of KPNA3 by LncRNA DLEU1 Leads to the Advancement of Colorectal Cancer -- CONCLUSION -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Pathways in Colorectal Cancer -- Ajay Madrewar1,*, Kapil Gore1 and Sankha Bhattacharya1 -- INTRODUCTION -- CHROMOSOMAL INSTABILITY PATHWAY -- Adenomatous Polyposis Coli gene and wnt Signaling Pathway -- TP-53 Mutation -- 18q Loss of Heterozygosity (LOH) -- MICROSATELLITE INSTABILITY PATHWAY -- EPIGENETIC INSTABILITY AND CPG METHYLATION -- PI3K/AKT PATHWAY, PTEN, AND TGFΒR2 -- SIGNALLING PATHWAYS IN COLORECTAL CANCER -- EGFR/MAPK Signaling Pathway -- Notch Signaling Pathway -- PI3K Signaling Pathway -- TGF-βsignalling Pathway -- Wnt Pathway -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Radiotherapy in Colorectal Cancer -- Amit Page1, Dnyanesh Saindane2 and Sankha Bhattacharya2,* -- INTRODUCTION -- TYPES OF RADIATION THERAPY -- CLINICAL TRIALS OR RESEARCH STUDIES OF RADIATION AND CHEMO-RADIATION THERAPY IN COLORECTAL CANCER -- Neoadjuvant Radiation Therapy -- Probable Side Effects of Radiotherapy -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Surveillance for Colorectal Cancer -- Saurabh Maru1, Kapil Gore1 and Sankha Bhattacharya1,*.
INTRODUCTION -- COLONOSCOPY -- FLEXIBLE SIGMOIDOSCOPY -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Recent Theranostics in Treatment of Colorectal Cancer -- Shilpa Dawre1, Ajay Madrewar1 and Sankha Bhattacharya1,* -- INTRODUCTION -- NANOFLATFORMS FOR DRUG DELIVERY AND THERANOSTICS -- NANOLIPOSOMAL BASED THERANOSTIC NANOPARTICLES -- Prodrug Approach -- SUPER MAGNETIC IRON-OXIDE NANOPARTICLES (SPIONS) -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Management of Colorectal Cancer -- Sankha Bhattacharya1, Amit Page1, Saurabh Maru1 and Shilpa Dawre1 -- MANAGEMENT OF COLORECTAL CANCER -- HOW CAN YOU PREPARE PATIENTS FOR SURGERY? -- Enhanced Recovery After Surgery (ERAS) -- Stomal Therapy -- Bowel Preparation -- Nutritional Interventions -- LOCAL RECTAL TREATMENT OF RECTAL CANCER (CLINICS IN THE COLON A RECTAL) -- Tumor Evaluation -- Electrocoagulation -- Contract Radiotherapy -- Local Excision -- ENDOSCOPIC TREATMENT -- Snare Polypectomy -- Endoscopic Mucosal Resection (EMR) -- Endoscopic Submucosal Dissection -- WHAT IS THE SURGICAL OPTION FOR COLORECTAL CANCER? -- Open Surgery -- Laparoscopic Surgery -- WHAT ARE POSSIBLE COMPLICATIONS? -- Immediate -- Long Term -- WHAT IS THE ROLE OF ADJUVANT CHEMOTHERAPY IN COLORECTAL CANCER TREATMENT? -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover.
Record Nr. UNINA-9910820215503321
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging technologies in agriculture and food science / / edited by Karim Ennouri
Emerging technologies in agriculture and food science / / edited by Karim Ennouri
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020]
Descrizione fisica 1 online resource (157 pages)
Disciplina 338.16
Soggetto topico Agricultural innovations
Food science - Technological innovations
ISBN 981-14-7000-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910794469603321
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging technologies in agriculture and food science / / edited by Karim Ennouri
Emerging technologies in agriculture and food science / / edited by Karim Ennouri
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020]
Descrizione fisica 1 online resource (157 pages)
Disciplina 338.16
Soggetto topico Agricultural innovations
Food science - Technological innovations
ISBN 981-14-7000-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910829145303321
Singapore : , : Bentham Science Publishers Pte. Ltd., , [2020]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui